BG60737B2 - Сърфактант подобни състави - Google Patents

Сърфактант подобни състави Download PDF

Info

Publication number
BG60737B2
BG60737B2 BG098075A BG9807593A BG60737B2 BG 60737 B2 BG60737 B2 BG 60737B2 BG 098075 A BG098075 A BG 098075A BG 9807593 A BG9807593 A BG 9807593A BG 60737 B2 BG60737 B2 BG 60737B2
Authority
BG
Bulgaria
Prior art keywords
surfactant
fatty alcohol
weight
compositions
synthetic
Prior art date
Application number
BG098075A
Other languages
Bulgarian (bg)
English (en)
Inventor
John Clements
Original Assignee
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Regents Of The University Of California filed Critical The Regents Of The University Of California
Publication of BG60737B2 publication Critical patent/BG60737B2/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Dental Preparations (AREA)
BG098075A 1980-10-24 1993-08-26 Сърфактант подобни състави BG60737B2 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/200,216 US4312860A (en) 1980-10-24 1980-10-24 Lung surfactant compositions

Publications (1)

Publication Number Publication Date
BG60737B2 true BG60737B2 (bg) 1996-01-31

Family

ID=22740789

Family Applications (1)

Application Number Title Priority Date Filing Date
BG098075A BG60737B2 (bg) 1980-10-24 1993-08-26 Сърфактант подобни състави

Country Status (9)

Country Link
US (1) US4312860A (enExample)
EP (1) EP0050793B1 (enExample)
JP (1) JPS5799524A (enExample)
AT (1) ATE7853T1 (enExample)
BG (1) BG60737B2 (enExample)
CA (1) CA1184503A (enExample)
CS (1) CS384991A3 (enExample)
DE (2) DE3164207D1 (enExample)
NL (1) NL930059I2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229179C2 (de) * 1982-08-05 1986-04-17 A. Nattermann & Cie GmbH, 5000 Köln Lungensurfactant
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
US5840527A (en) * 1984-12-11 1998-11-24 Byk Gulden Lomberg Chemische Fabrik Gmbh Recombinant alveolar surfactant protein
US4659805A (en) * 1984-12-11 1987-04-21 California Biotechnology, Inc. Recombinant alveolar surfactant protein
US5169761A (en) * 1984-12-11 1992-12-08 California Biotechnology Inc. Dna encoding and expression systems for alveolar surfactant proteins
US4933280A (en) * 1984-12-11 1990-06-12 California Biotechnology Inc. Recombinant DNA sequence encoding Alveolar Surfactant Protein
ATE78158T1 (de) * 1985-05-22 1992-08-15 Liposome Technology Inc Verfahren und system zum einatmen von liposomen.
US5110806A (en) * 1985-06-26 1992-05-05 The Regents Of The University Of California Lung surfactant compositions
US4826821A (en) * 1985-06-26 1989-05-02 The Regents Of The University Of California Lung surfactant compositions
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
US4812314A (en) * 1986-02-24 1989-03-14 Yissum Research & Dev. Co. Of The Hebrew Univ. Of Jerusalem And Hadassah Medical Organization Lipid replacement therapy
US5013720A (en) * 1986-05-06 1991-05-07 Abbott Laboratories SAP-6-Val proteins and methods
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
IT1203873B (it) * 1987-04-08 1989-02-23 Chiesi Farma Spa Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e
US4861756A (en) * 1988-03-08 1989-08-29 Merrell Dow Pharmaceuticals Inc. Synthetic pulmonary surfactant
US5207220A (en) * 1989-12-12 1993-05-04 Burroughs Wellcome Co. Method for administering pharmaceuticals, including liquid surfactant, to the lungs
US5614216A (en) * 1990-10-17 1997-03-25 The Liposome Company, Inc. Synthetic lung surfactant
GB9120005D0 (en) * 1991-09-19 1991-11-06 Wellcome Found Method of administering phospholipid dispersions
US5622715A (en) * 1994-06-10 1997-04-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of improving renal function
US6235308B1 (en) 1994-06-10 2001-05-22 Yissum Research Development Company Of The Hebrew University Of Jerusalem Method of treating hypertension
US5698537A (en) * 1996-06-18 1997-12-16 Clarion Pharmaceuticals Inc. Method of lowering the viscosity of mucus
US5883084A (en) * 1998-06-08 1999-03-16 Clarion Pharmaceuticals Inc. Treatment of respiratory diseases utilizing α-tocopheryl-phosphocholine
US6180142B1 (en) * 1998-08-21 2001-01-30 The Regents Of The University Of California Reduction of surfactant inactivation in pulmonary surfactant therapy
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
CA2401308A1 (en) 2000-03-13 2001-09-20 Klaus D. Hagspiel Diagnostic procedures using direct injection of gaseous hyperpolarized 129xe and associated systems and products
GB0026239D0 (en) * 2000-10-26 2000-12-13 Britannia Pharmaceuticals Ltd Surface active lipids in treatment of wet lung
US8029815B2 (en) * 2004-04-28 2011-10-04 Elford Howard L Methods for treating or preventing restenosis and other vascular proliferative disorders
JPWO2005105111A1 (ja) * 2004-04-29 2008-07-31 相男 李 人工肺サーファクタント組成物およびその使用方法
EP2211956A4 (en) * 2007-10-10 2014-07-09 Parion Sciences Inc DISPOSAL OF OSMOLYTES WITH A NOSE CANNULA
US8778383B2 (en) 2011-06-07 2014-07-15 Parion Sciences, Inc. Methods of treatment
US8945605B2 (en) 2011-06-07 2015-02-03 Parion Sciences, Inc. Aerosol delivery systems, compositions and methods
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
DK2855435T3 (en) 2012-05-29 2018-07-16 Parion Sciences Inc DENDRIMER-LIKE AMINOAMIDES WITH SODIUM CHANNEL BLOCKING ACTIVITY FOR THE TREATMENT OF DRY EYES AND OTHER MILK DISEASES
ES2674665T3 (es) 2012-12-17 2018-07-03 Parion Sciences, Inc. Compuestos de 3,5-diamino-6-cloro-N-(N-(4-fenilbutilo)carbamimidoilo)-pirazina-2-carboxamida
US9029382B2 (en) 2012-12-17 2015-05-12 Parion Sciences, Inc. 3,5-diamino-6-chloro-N-(N-(4-phenylbutyl)carbamimidoyl) pyrazine-2-carboxamide compounds
BR112015014349A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc derivados de cloro-pirazina carboxamida úteis para o tratamento de doenças favorecidas por hidratação mucosa insuficiente
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE388023C (de) * 1922-02-14 1924-01-07 Chem Fab Verfahren zur Herstellung von waesserigen Lezithinemulsionen
US3577446A (en) * 1968-09-09 1971-05-04 American Home Prod Phosphatidylalkanolamine derivatives
DE2629135A1 (de) * 1976-06-29 1978-01-12 Nattermann A & Cie Neue phospholipid-derivate von prostaglandinen und verfahren zu ihrer herstellung
DE2900300A1 (de) * 1979-01-05 1980-07-17 Lebrecht Von Dr Klitzing Verfahren einer prophylaxe zur vermeidung des atemnotsyndroms bei fruehgeborenen und bei der schocklunge

Also Published As

Publication number Publication date
DE19375071I2 (de) 2006-05-04
ATE7853T1 (de) 1984-06-15
NL930059I1 (nl) 1993-09-01
DE3164207D1 (en) 1984-07-19
JPH0343252B2 (enExample) 1991-07-01
EP0050793B1 (en) 1984-06-13
NL930059I2 (nl) 1994-01-03
EP0050793A1 (en) 1982-05-05
CA1184503A (en) 1985-03-26
CS384991A3 (en) 1992-10-14
US4312860A (en) 1982-01-26
JPS5799524A (en) 1982-06-21

Similar Documents

Publication Publication Date Title
BG60737B2 (bg) Сърфактант подобни състави
US4826821A (en) Lung surfactant compositions
Morley et al. Dry artificial lung surfactant and its effect on very premature babies
JP2700323B2 (ja) 肺動脈界面活性剤、その調製方法、及び薬剤組成物
US4423077A (en) Perfluorochemical emulsion artificial blood
US4765987A (en) Artificial surfactants, pharmaceutical compositions containing them and use thereof
US5299566A (en) Method of administering phospholipid dispersions
EP0055041B1 (en) Composition for curing respiratory diseases
EP0119056B1 (en) Surfactant composition and pharmaceutical compositions containing same for use in the treatment of respiratory distress syndrome
CA1205387A (en) Artificial lung surfactant and remedy for respiratory distress syndrome containing it as active principle
KR20030053507A (ko) 동적-팽창 작용을 하는 폐계면활성제 조성물
KR100342806B1 (ko) 신규합성펩티드,이를함유하는폐표면활성제및호흡장애증후군치료제
Vidyasagar et al. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease
US5110806A (en) Lung surfactant compositions
EP0069399B1 (en) Pharmaceutical composition containing ubidecarenone containing liposomes
US4497829A (en) Process for preparing perfluorochemical emulsion artificial blood
US4386077A (en) Pharmaceutical composition for oral administration containing cytidine diphosphocholine
Walther et al. Prevention of oxygen toxicity with superoxide dismutase and catalase in premature lambs
EP2538960A1 (en) Surfactant composition
JP3376582B2 (ja) 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
PT94574B (pt) Processo para a preparacao de suspensoes de agentes tensio-activos muito concentradas e de pequena viscosidade
Bazil et al. Equilibration of halothane with brain tissue in vitro: comparison to brain concentrations during anesthesia
JPWO1993021225A1 (ja) 合成ペプチド、それを含有する肺サーファクタント及び呼吸窮迫症候群治療剤
Scarpelli et al. Demonstration of the significance of pulmonary surfactants at birth
KR100191899B1 (ko) 합성 펩타이드를 이용한 폐 계면활성제